Evidence map›Paper›PMID 40793996›Full record

ArticleJournal of pediatric orthopedics2026

Management of Pediatric Medial Epicondyle Fractures: Results of a Survey of the Pediatric Orthopaedic Society of North America (POSNA).

Ameen Barghi, Jamie Burgess, Xavier Lacoste, Max J Hyman, Joseph A Janicki, Collin May

Abstract read
In one paragraph

Article in Journal of pediatric orthopedics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ameen BarghiDepartment of Orthopaedic Surgery, Atrium Health Wake Forest Baptist, Winston-Salem, NC.
Jamie BurgessAnn and Robert H. Lurie Children's Hospital of Chicago.
Xavier LacosteBoston Children's Hospital, Boston, MA.
Max J HymanThe Center for Health and the Social Sciences, The University of Chicago, Chicago, IL.
Joseph A JanickiAnn and Robert H. Lurie Children's Hospital of Chicago.
Collin MayBoston Children's Hospital, Boston, MA.ORCID 0000-0003-3072-7289

Funding

IMPACCT – Infrastructure for Musculoskeletal Pediatric Acute Care Clinical TrialsR34AR075303 · NIAMS · LURIE CHILDREN'S HOSPITAL OF CHICAGO · PI JANICKI, JOSEPH A · 2019 to 2020
$478k
NIAMS NIH HHS R34 AR075303NIH IMPACCT (Infrastructure for Musculoskeletal Pediatric Acute Care Clinical Trials) grant number R34 AR075303
6 · The paper itself

Abstract

backgroundFractures involving the medial humeral epicondyle are common but no consensus on the best treatment approach exists. Casting alone and open reduction with internal fixation (ORIF) both provide reliable healing, although there is limited evidence to support either approach. This study surveyed surgeons treatment preferences for pediatric medial epicondyle fractures (MEF) and willingness to randomize between casting and ORIF. We hypothesized that low consensus exists in the preferred treatment approach (casting vs. ORIF).

methodsAn online survey was emailed in 2017 to members of the Pediatric Orthopaedic Society of North America (POSNA). Demographic information regarding orthopaedic surgeon practice experience and setting, in addition to opinions regarding MEF treatment, were collected. Seven patient cases were presented to assess the surgeon's preferred treatment approach and willingness to randomize treatment.

resultsThe survey was completed by 322 POSNA members (∼25% of membership). Respondents were well-represented by POSNA with 55.7% <9, 23.8% 10 to 19, and 20.5% ≥20 years in practice. Most respondents were from an academic setting (77.4%), taught residents (83.3%), and treated primarily pediatric patients (91.6%). Years of experience significantly influenced both their treatment preferences and willingness to randomize, while practice setting only influenced the latter. Factors that influenced treatment approach included chronological/skeletal age (64.2%), known elbow dislocation (74.1%), neurovascular status (65.3%), and the amount of fragment displacement (80.4%). Displacement contributed to the treatment decision with 1.1% opting to operate at any displacement, 2.7% at >2 mm, 24.6% at >5 mm, 27.7% at >10 mm, and 43.9% choosing to analyze factors beyond displacement. Immobilization length varied between the treatments with 63.6% recommending immobilization of ≥4 weeks for casting and 81.9% recommending immobilization of ≤2 weeks for ORIF. The greatest consensus (87%) for ORIF was found in a 14-year-old with a fracture fragment displaced >10 mm, with no elbow dislocation and in the nondominant arm, neurovascularly intact. The lowest consensus (50.9% recommending ORIF) was in an 11-year-old with a fracture fragment displaced >10 mm, with no elbow dislocation and in the nondominant arm, neurovascularly intact. For these cases, 48% and 60% of surgeons were willing to randomize treatment, respectively. For the 7 cases overall, a mean of 58% (range: 48% to 63%) of respondents were willing to randomize treatment.

conclusionA lack of standardization exists for the preferred treatment approach for pediatric MEF. The decision to pursue casting or ORIF appears multifactorial. Roughly half of the respondents would be willing to randomize the treatment of these injuries.

Indexed as

Casts, SurgicalFracture Fixation, InternalHumeral FracturesOpen Fracture ReductionPractice Patterns, Physicians'AdolescentChildFemaleHumansMaleNorth AmericaOrthopedic SurgeonsSocieties, MedicalSurveys and Questionnairescasting versus open reduction with internal fixation (ORIF)pediatric medial epicondyle fractures (MEF)randomization of MEF treatmentsurgeon treatment preferencestreatment approach for MEF

Identifiers

PMID40793996
PMCPMC12688462

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.